Caldas, Stella
Pagan, Angel D
Pulsinelli, Juliana
da Rosa, Joel Correa
Jung, Seungyeon
Sharma, Divija
Adalsteinsson, Jonas A
Ungar, Benjamin
Article History
Received: 31 January 2024
Revised: 21 April 2024
Accepted: 26 April 2024
First Online: 22 May 2024
Declarations
:
: BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from: Incyte, Rapt Therapeutics, and Pfizer. He is also a consultant for Arcutis Biotherapeutics, Bristol Myers Squibb, Castle Biosciences, Fresenius Kabi, Galderma, Pfizer, Sanofi, and UCB. JCDR is an employee of Mount Sinai. JAA is an employee of Mount Sinai. The rest of the authors declare no relevant conflicts of interest.